• Explore /
  • Poster
  • / Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: Results of GASTric cancer HER2 reassessment study 3 (GASTHER3).

Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: Results of GASTric cancer HER2 reassessment study 3 (GASTHER3).

Abstract Poster

Authors

null

Seyoung Seo

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Seyoung Seo , Min-Hee Ryu , Ji Yong Ahn , Yangsoon Park , Sook Ryun Park , Baek-Yeol Ryoo , Young Soo Park , Gin Hyug Lee , Hwoon-Yong Jung , Yoon-Koo Kang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Prevention, Diagnosis, and Screening

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 27)

DOI

10.1200/JCO.2017.35.4_suppl.27

Abstract #

27

Poster Bd #

E5

Abstract Disclosures

Similar Posters

First Author: Anna Dorothea Wagner

Poster

2013 Gastrointestinal Cancers Symposium

Significance of accurate HER2 testing as a new biomarker in advanced gastric cancer.

Significance of accurate HER2 testing as a new biomarker in advanced gastric cancer.

First Author: Tetsuya Kusumoto

First Author: Sun Young Rha

First Author: Beate Rau